Planning Strategies’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$536 Buy
12
+4
+50% +$227 ﹤0.01% 918
2026
Q2
$634 Buy
+8
New +$602 ﹤0.01% 816

Other funds holding IONS

Planning Strategies's IONS Position: Q3 2026 in Review

Planning Strategies increased its Ionis Pharmaceuticals (IONS) stake by 50% in Q3 2026, buying an estimated $227 and bringing the position to 12 shares worth $536. The position accounts for ﹤0.01% of the portfolio, ranked #918.

Planning Strategies first reported a position in IONS in Q2 2026 and has held it in 2 quarters since. The position peaked at $634 in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Planning Strategies held 12 shares of Ionis Pharmaceuticals worth $536 as of Q3 2026.
  • Planning Strategies bought 4 Ionis Pharmaceuticals shares in Q3 2026, an estimated $227.
  • Ionis Pharmaceuticals made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #918 holding.
  • Planning Strategies first reported a position in Ionis Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Planning Strategies's Ionis Pharmaceuticals position peaked at $634 in Q2 2026.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.